SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-007808
Filing Date
2004-03-15
Accepted
2004-03-12 21:45:31
Documents
9
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2130713z10-k.htm 10-K 733409
3 EXHIBTI 10.44 a2130713zex-10_44.htm EX-10.44 132724
4 EXHIBIT 10.45 a2130713zex-10_45.htm EX-10.45 125970
5 EXHIBIT 10.46 a2130713zex-10_46.htm EX-10.46 84870
6 EXHIBIT 14 a2130713zex-14.htm EX-14 31351
7 EXHIBIT 23.1 a2130713zex-23_1.htm EX-23.1 2232
8 EXHIBIT 31.1 a2130713zex-31_1.htm EX-31.1 5590
9 EXHIBIT 31.2 a2130713zex-31_2.htm EX-31.2 5590
10 EXHIBIT 32.1 a2130713zex-32_1.htm EX-32.1 4214
  Complete submission text file 0001047469-04-007808.txt   1128377
Mailing Address 2292 FARADAY AVE CARLSBAD CA 92008
Business Address 2292 FARADAY AVE CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19125 | Film No.: 04667556
SIC: 2834 Pharmaceutical Preparations